In an interim statement on the 19 July, the JCVI stated that:
“Taking the evidence as a whole the Committee therefore is unable to recommend extension of the national HPV programme to adolescent boys according to the most robust cost-effectiveness analyses undertaken.”
It also recognised arguments made by stakeholders on the issue of equality of access and noted that these require consideration.
A copy of the statement from 19 July is attached.
The JCVI is consulting on these interim findings. Subject to the results of the consultation, the JCVI’s final advice is expected in November. The Department will consider and respond to this final advice in due course.